RNL BIO Co., Ltd. is a Korea-based company engaged in the manufacture of cell therapy products. The Company provides three categories of products: stem cells, including lipostem-femoran remedies for hip joint fracture, lipostem-DM remedies for diabetes mellitus, astrostem remedy for spinal cord injury, vascostem remedies for ischemic cardiac and cerebral infarction and cancerstem remedies for cancers; endocrine remedies for anti diabetes mellitus, growth promotion and diet, and stem cell cosmetics. It also engaged in the provision of bio safety products, including disinfectant for animals, and fashion business. On May 30, 2011, the Company acquired additional shares of RNLNATURALLIFE.CO.,LTD, raising its stake in the latter to 63.30%. On December 16, 2011, the Company spun-off its fashion, animal and investment business into wholly owned subsidiaries.